5th Gene Therapy for Neurological Disorders 2023 Boston Park Plaza, Boston
Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the potential that gene therapies can act as transformative medicines within the CNS community.
The 5th Gene Therapy for Neurological Disorders Summit is your comprehensive 4-day event to stay ahead of cutting-edge developments, overcome delivery challenges, address translational bottlenecks, and create a bulletproof clinical development strategy, to propel the next wave of CNS gene therapies forward.
This summit will unite 200+ gene therapy and neurology leaders with a program designed to cater to everyone from Discovery through to Clinical Development; this is your only opportunity for a cover-to-cover discussion full of need-to-know and practical insights.
Now that the neurological gene therapy field has been given a renewed sense of direction, this is the opportunity for the community to capitalize on the start of a new wave of innovation and optimize the potential for gene therapies targeting neurological disorders.
⌛ Event Dates & Venue
👨👧👦 Social Networks
💸 Website & Tickets
Go to Event Website Drug Developer Pricing - Full Access Pass (2 Day Conference + Pre-Conference Workshop Day AND Post-Conference Delivery Day): USD 5195.00, Drug Developer Pricing - 2 Day Conference + Workshop Day OR Post Conference Delivery Day: USD 4097.00, Drug Developer Pricing - 2 Day Conference Only: USD 2999.00, Solution Provider Pricing - Full Access Pass (2 Day Conference + Pre-Conference Workshop Day AND Post-Conference Delivery Day): USD 6395.00, Solution Provider Pricing - 2 Day Conference + Workshop Day OR Post Conference Delivery Day: USD 5097.00, Solution Provider Pricing - 2 Day Conference Only: USD 3799.00
Advertisements